Amarin Corp Plc (AMRN)

[sstyles]

Check mate. I encourage everyone to read the complaint. You can find it on FAQs on Amarin's website.

The GSK v. Teva case served as a roadmap for Amarin on how to "catch" Hikma in the act and Hikma's own actions from its press releases to altering its website post the GSK v. Teva decision underscore this point. Even though GSK v. Teva is not mentioned, we have the same counsel as GSK (Singer) and you can tell Hikma fell right into the trap via their own actions post that ruling. And Amarin even cited to Hikma's expert about alternative uses of Vascepa aside from the severe HTG indication. Genius.

Not to mention the Indications & Usage section of Hikma's generic label did not contain a limitation for CV usage.
"Like the current VASCEPA® label, Hikma’s Label does not include the CV Limitation of Use."

Asking for a permanent injunction was great because it boxes Hikma in to just the MARINE indication, which is really all they are entitled too based on Judge Du's decision.

Check Mate. Hikma's hands were in the cookie jar and they were caught with the cookie (press releases, website changes, and no CV limitation).